Sigma Healthcare Limited (ASX:SIG)

ALERT: Price-sensitive ASX Announcement for SIG

Current share price for SIG : $2.800 -0.19 (-6.35%)⁺

Announcement

Sigma Half Year Results ASX Release

Release

26 Feb 2026 8:24AM

Price at Release

$2.990

Full Release

Summary

Sigma Healthcare Limited reported strong financial performance for the half year ending 31 December 2025, driven by significant sales and profit growth. The company achieved double-digit increases in normalised EBIT and NPAT, supported by robust expansion in both domestic and international markets. Sigma's Australian Chemist Warehouse branded store sales saw a notable rise, contributing to the overall revenue growth. In addition, the company successfully reduced net debt and announced a fully franked interim dividend. Sigma's strategic initiatives, including the introduction of new products and expansion into international markets like New Zealand and Ireland, underscore its commitment to long-term growth and shareholder value.

Key Points

Normalised EBIT increased by 18.7% to $582.9 million.
Normalised NPAT increased by 19.2% to $392.0 million.
Revenue grew by 14.9% to $5.5 billion.
Australian CW branded store sales rose by 17.2%, with LFL sales up 15.0%.
International growth saw retail network sales up 24.5%, LFL sales grew by 11.1%.
Net debt decreased by $117.1 million to $635.1 million.
The company declared an interim dividend of 2.0 cents per share.
Over 400 new owned and exclusive products added, contributing to a 15.7% sales growth.
The New Zealand business expanded to 70 stores with plans for further growth.
International retail network sales exceeded $807 million.

IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.